From January 1, 2022 to March 31, 2022, the company has repurchased 1,161,938 shares, representing 4.34% for $5.18 million. With this, the company has completed the repurchase of 1,931,014 shares, representing 7.13% for $8.56 million under the buyback announced on November 17, 2021.
La Jolla Pharmaceutical Company
Equities
LJPC
US5034596040
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+3.19% | 108B | |
+11.10% | 104B | |
+1.28% | 22.33B | |
-12.75% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.75% | 17.64B | |
+4.20% | 14.05B | |
+34.79% | 12.51B |